Budget and formulary information


DuoResp Spiromax could help you to help more patients with asthma and COPD

Click here for further information to support your formulary applications

DuoResp Spiromax could potentially provide annual savings of: £40.8m3*

DuoResp Spiromax 160/4.5mcg delivered dose
120-dose unit: £29.97

Symbicort Turbohaler® 200/6mcg metered dose
120-dose unit: £38

DuoResp Spiromax 320/9mcg delivered dose
60-dose unit: £29.97

Symbicort Turbohaler 400/12mcg metered dose
60-dose unit: £38

*Approximately 2.5% of PCO prescriptions have not been counted to account for patients under 18 years of age.3


References
1. Medical Design Excellence Awards 2015. Available at: www.devicelink.com/expo/awards/awards/.
Last accessed: February 2017.
2. MIMS. Available at: www.mims.co.uk. Last accessed: February 2017
3. HSCIC England, Wales NHS, HSCNI Northern Ireland September 2015 - August 2017, ISD Scotland July 2015 - June 2016

Based on generic and branded prescriptions for budesonide and formoterol 200/6 mcg and 400/12 mcg doses.

DuoResp Spiromax is licensed for patients aged 18 years of age and older. Approximately 2.5% of PCO prescriptions have not been counted to account for patients under 18.3

Range of 12-month period will differ depending on location of PCO:
- England, Wales and Northern Ireland: September 2015 - August 2016
- Scotland: July 2015 - June 2016